LDS/Medical Tests/DNA Cell Cycle Analysis by Flow Cytometry

DNA Cell Cycle Analysis by Flow Cytometry

Measurement of DNA ploidy (the amount of DNA material present in cells including tumor cells) and S-Phase Fraction (SPF, the percent of cells actively dividing) provides useful information regarding the biological aggressiveness of malignant tumors. It is used predominantly in the analysis of breast carcinoma as a prognostic test. It has been shown that assessment of DNA ploidy and SPF correlate with tumor size, grade, nodal status, and overall survival. In general, increased SPF and/or aneuploidy (abnormal amount of DNA) are associated with a worse overall outcome. Exceptions include neuroblastoma and acute lymphoblastic leukemia of childhood. Testing can help plan management for patients with limited stage disease. Limitations include the inclusion of non-neoplastic tissue in the sample; hence, selection of malignant cells for analysis is critical for valid results. The inclusion of non-neoplastic tissue may lead to the inability to detect an abnormality.

Determination of DNA ploidy and S-Phase Fraction has been shown to be prognostically useful in many malignant neoplasms including primarily breast, but also colon, prostate, bladder, and lung. This can help guide the aggressiveness of therapy.
DNA Poidy: Normal cells contain a population of cells with a diploid (normal resting state, called 2C) number of chromosomes and a smaller population of actively dividing cells with double the normal amount of DNA (4C). Tumor cells often show deviation from this normal two-population state and can show many variations from normal, such as a much higher than normal number of cells with 4C DNA and cells with abnormal amounts of DNA, e.g., 5C, or multiple populations of abnormal cells each with an abnormal amount of DNA.

Normal: Diploid DNA content with a low S-Phase Fraction
 

 

Flow cytometry using Paraffin-embedded tissue. For flow cytometry, a cell suspension can be made and a fluorescent dye is added to the suspension and binds to DNA in a fixed ratio. The cells are passed through a laser counter and a percentage of cells containing specific amounts of DNA relative to normal is determined. For paraffin-embedded tissue, sections can be prepared and stained and individual cell nuclei can be visualized and the DNA content of each counted and then summarized. SPF is a calculated value and is not directly measured.

Fresh tumor tissue, frozen tumor tissue, formalin fixed paraffin-embedded tissue, adequately cellular body fluid, fine needle aspiration cellular material. Fresh tissue requires immediate processing. Frozen tissue must remain frozen until used for testing. Paraffin-embedded tissue is stable for years.

Hormone prognostic testing such as estrogen and progesterone receptor testing, Her-2/neu in breast cancer, Ki-67 proliferation testing, multiple gene profiling.
3-5 business days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login